Dyadic International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
$DYAI
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported) : June 11, 2024
(Exact name of registrant as specified in its charter)
|
(State or other jurisdiction of
incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
|
|
||
|
(Address of principal executive offices and zip code)
|
||
|
(
|
||
|
(Registrant’s telephone number, including area code)
|
||
|
N/A
(Former Name or Former Address, if Changed Since Last Report)
|
||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||||||
|
|
|
The
|
Item 5.07 Submission of Matters to a Vote of Security Holders
On June 11, 2024, Dyadic International, Inc. (“Dyadic” or the “Company”) held its 2024 Annual Meeting of Shareholders (the “2024 Annual Meeting”). The final voting results with respect to each proposal voted upon at the 2024 Annual Meeting are set forth below:
Proposal 1: Election of Class II Directors to hold office until the 2027 Annual Meeting of Shareholders.
|
Nominee
|
For
|
Withheld
|
Broker Non-Votes
|
|||||||
| Jack L. Kaye | 14,971,570 | 1,489,677 | 7,115,287 | |||||||
| Patrick Lucy | 15,039,453 | 1,421,794 | 7,115,287 |
Proposal 2: Ratification of Appointment of Crowe LLP as the Company's Independent Registered Public Accounting Firm for the current fiscal year ending December 31, 2024.
|
For
|
% Votes Cast For
|
Against
|
Abstained
|
Broker Non-Votes
|
|||||||||
| 23,400,950 | 99.78 | % | 49,863 | 125,721 | — |
Proposal 3: Advisory Vote on compensation of the Company's Named Executive Officers.
|
For
|
% Votes Cast For
|
Against
|
Abstained
|
Broker Non-Votes
|
|||||||||
| 15,543,521 | 97.76 | % | 354,798 | 562,928 | 7,115,287 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 11, 2024
|
Dyadic International, Inc.
|
||
|
By:
|
/s/ Ping W. Rawson
|
|
|
Name:
|
Ping W. Rawson
|
|
|
Title:
|
Chief Financial Officer
|
|